Does sublingual 17β-oestradiol have any effects on exercise capacity and myocardial ischaemia in post-menopausal women with stable coronary artery disease?

European Heart Journal

Volumn 19, Issue 7, 1998, Pages 1019-1026

  Al Khalili, Faris ^a   Landgren, B M ^a   Eksborg, S ^a   Franco Cereceda, A ^a   Schenck Gustafsson, K ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

17 oestradiol; Coronary artery disease; Endothelin 1; Exercise test; Post menopausal women

Indexed keywords

ENDOTHELIN 1; ESTRADIOL; ESTROFEM; GLYCERYL TRINITRATE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BUCCAL DRUG ADMINISTRATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT DEPRESSION; SUBLINGUAL DRUG ADMINISTRATION; TIME;

ADMINISTRATION, SUBLINGUAL; CORONARY DISEASE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; ENDOTHELIN-1; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; EXERCISE TEST; FEMALE; HUMANS; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NITROGLYCERIN; POSTMENOPAUSE; TREATMENT OUTCOME;

EID: 0032127255     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1998.0975     Document Type: Article

References (32)

1. [1] Stampfer M, Golditz G. Estrogen replacement therapy and coronary heart disease. A quantitative assessment of the epidemiologic evidence. Prev Med 1991; 20: 47-63.
2. [2] Barrett-Connor E, Miller V. Estrogens, lipids and heart disease. Clin Geriatr Med 1993; 9: 57-67.
3. [3] Bush TL, Barrett-Connor E, Cowan LD et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the lipid research clinics program follow-up study. Circulation 1987; 75: 1102-9.
4. [4] Chester AH, Jiang C, Borland JA, Yacoub MH, Collins P. Estrogen relaxes human epicardial coronary arteries through non-endothelium-dependent mechanisms. Cor Art Dis 1995; 6: 417-22.
5. [5] Mügge A, Riedel M, Barton M, Kuhn M, Lichtlen PR. Endothelium independent relaxation of human coronary arteries by 17 B-estradiol in vitro. Cardiovasc Res 1993; 27: 1939-42.
6. [6] Volterrani M, Rosano GMC, Coats A, Beale C, Collins P. Estrogen acutely increases peripheral blood flow in postmenopausal women. Am J Med 1995; 99: 119-22.
7. [7] Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon III RO. Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women. Am J Cardiol 1995; 75: 264-8.
8. [8] Reis SE, Gloth ST, Blumenthal RS et al. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopasual women. Circulation 1994; 89: 52-60.
9. [9] Gilligan DM, Quyyumi AA, Cannon III RO.Effects of physiological levels of estrogen on coronary vasomotor function in postmenopasual women. Circulation 1994; 89: 2545-51.
10. [10] Collins P, Rosano GMC, Sarrel PM et al 17Beta-Estradiol attenuates acetylcholine-induced coronary arterial vasoconstriction in women but not in men with coronary heart disease. Circulation 1995; 92: 24-30.
11. [11] Rosano GMC, Caixeta AM, Arie S et al. Acute-ischemic effects of 7β-estradiol in menopausal women with coronary artery disease. Eur Heart J 1996; 17 (Abstr Suppl): 433, p2348.
12. [12] Hale S, Birnbaum Y, Kloner R. Beta-estradiol, but not alpha-estradiol, reduced myocardial necrosis in rabbits after ischemia and reperfusion. Am Heart J 1996; 132: 258-62.
13. [13] Venkov C, Rankin A, Vaughan D. Identification of authentic estrogen receptor in cultured endothelial cells - a potential mechanism for steroid hormone regulation of endothelial function. Circulation 1996; 94: 727-33.
14. [14] Kimschulze S, Mcgowan K, Hubchak S et al. Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation 1996; 94: 1402-7.
15. [15] Collins P, Rosano GMC, Jiang C, Lindsay D, Sarrel PM, Poole-Wilson PA. Cardiovascular protection by estrogen - a calcium antagonist effect. Lancet 1993; 341: 1264-5.
16. [16] Kauser K, Rubanyi GM. 17Beta-estradiol and endothelial nitric oxide synthase. Endothelium 1994; 2: 203-8.
17. [17] Collins P, Shay J, Jiang C, Moss J. Nitric oxide accounts for dose-dependent estrogen-mediated coronary relaxation after acute estrogen withdrawal. Circulation 1994; 90: 1964-8.
18. [18] Sack MN, Rader DJ, Cannon III RO. Estrogen and inhibition of LDL in postmenopausal women. Lancet 1994; 343: 269-70.
19. [19] Jiang C, Sarrel PM, Poole-Wilson PA, Collins P. Acute effect of 17B estradiol on rabbit coronary artery contractile responses to endothelin-1. Am J Physiol 1992; 263: H271-5.
20. [20] Rosano GMC, Sarrel PM, Poole-Wilson PA, Collins P. Beneficial effect of estrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet 1993; 342: 133-6.
21. [21] Patel D, Mulcahy D, Norrie J et al. Does the exercise protocol matter when assessing the anti-anginal effects of drug therapy? Eur Heart J 1995; 16: 1773-9.
22. [22] Olsson G, Oden A, Johansson L, Sjögren A, Rehnqvist N. Prognosis after withdrawal of chronic postinfarction metoprolol treatment: a 2-7 year follow-up. Eur Heart J 1988; 9: 3656-72.
23. [23] Holdright DR, Sullivan AK, Wright CA, Sparrow JL, Cunningham D, Fox KM. Acute effects of estrogen replacement therapy on treadmill performance in postmenopausal women with coronary artery disease. Eur Heart J 1995; 16: 1566-70.
24. [24] Landgren BM, Undén AL, Diczfalusy E. Hormonal profile of the cycle in 68 normally menstruating women. Acta Endocrinologica 1980; 94: 89-98.
25. [25] Greengart A, Lichstein D, Hollander G, Bolton S, Sanders M. Efficacy of sustained-release buccal nitroglycerine in patients with angina pectoris. Chest 1983; 83: 473-9.
26. [26] Yanagisawa M, Kurihara H, Kimura S et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-5.
27. [27] Tonnessen T, Naess PA, Kirkeboen KA, Offstad J, Ilebekk A, Christensen G. Release of endothelin from the porcine heart after short term coronary artery occlusion. Cardiovasc Res 1993; 27: 1482-5.
28. [28] Polderman K, Stehouwer V, van Kamp G, Dekker G, Verbeugt F, Gooren L. Influence of sex hormones on plasma endothelin levels. Ann Int Med 1993; 118: 429-32.
29. [29] Richter EA, Emmeluth C, Bie P, Helge J, Kiens B. Biphasic response of plasma endothelin-1 concentration to exhausting submaximal exercise in man. Clin Physiol 1994; 14: 379-84.
30. [30] Predel H-G, Knigge H, Prinz U, Kramer H, Stalleicken D, Rost R. Exercise increases endothelin-1 plasma concentrations in patients with coronary artery disease: modulatory role of LDL1 cholesterol and of pentaerithrityltetranitrate. J Cardiovasc Pharmacol 1995; 26: 497-501.
31. [31] Letzia C, Barilla F, Cerci S et al. Dynamic exercise induces elevation of plasma levels of endothelin-1 in patients with coronary artery disease. Angiology 1995; 46: 819-26.
32. [32] Wingrove C, Stevenson J. Effect of 17β-estradiol on endothelin-1 release by human umbilical vein endothelial cells. Eur Heart J 1996; 17 (Abstr Suppl): p2257.